894 related articles for article (PubMed ID: 18215609)
21. Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE).
Alexander D; Ou FS; Roe MT; Pollack CV; Ohman EM; Cannon CP; Gibler WB; Fintel DJ; Peterson ED; Brown DL;
Am Heart J; 2008 Sep; 156(3):606-12. PubMed ID: 18760147
[TBL] [Abstract][Full Text] [Related]
22. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
Nguyen MC; Lim YL; Walton A; Lefkovits J; Agnelli G; Goodman SG; Budaj A; Gulba DC; Allegrone J; Brieger D;
Eur Heart J; 2007 Jul; 28(14):1717-22. PubMed ID: 17562671
[TBL] [Abstract][Full Text] [Related]
23. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
Hermosillo AJ; Spinler SA
Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
[TBL] [Abstract][Full Text] [Related]
24. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.
Smith JG; Wieloch M; Koul S; Braun OÖ; Lumsden J; Rydell E; Ohman J; Scherstén F; Svensson PJ; van der Pals J
EuroIntervention; 2012 Oct; 8(6):672-8. PubMed ID: 23086784
[TBL] [Abstract][Full Text] [Related]
25. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III.
Cohen M; Diez JE; Levine GN; Ferguson JJ; Morrow DA; Rao SV; Zidar JP; ;
J Invasive Cardiol; 2007 Dec; 19(12):525-38; quiz 539-40. PubMed ID: 18180524
[TBL] [Abstract][Full Text] [Related]
26. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
Wang TY; Ou FS; Roe MT; Harrington RA; Ohman EM; Gibler WB; Peterson ED
Circulation; 2009 May; 119(18):2454-62. PubMed ID: 19398666
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.
Khurram Z; Chou E; Minutello R; Bergman G; Parikh M; Naidu S; Wong SC; Hong MK
J Invasive Cardiol; 2006 Apr; 18(4):162-4. PubMed ID: 16729401
[TBL] [Abstract][Full Text] [Related]
28. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention.
Denardo SJ; Davis KE; Tcheng JE
Am J Cardiol; 2007 Nov; 100(9):1376-82. PubMed ID: 17950793
[TBL] [Abstract][Full Text] [Related]
30. The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
Amad H; Yan AT; Yan RT; Huynh T; Gore JM; Montalescot G; DeYoung JP; Gallo R; Rose B; Steg PG; Goodman SG;
Can J Cardiol; 2012; 28(1):48-53. PubMed ID: 22112683
[TBL] [Abstract][Full Text] [Related]
31. Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes.
Riezebos RK; Ronner E; Ter Bals E; Slagboom T; Smits PC; ten Berg JM; Kiemeneij F; Amoroso G; Patterson MS; Suttorp MJ; Tijssen JG; Laarman GJ;
Heart; 2009 May; 95(10):807-12. PubMed ID: 19098058
[TBL] [Abstract][Full Text] [Related]
32. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
[TBL] [Abstract][Full Text] [Related]
33. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
Spinler SA
Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
[TBL] [Abstract][Full Text] [Related]
35. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
Helft G; Gilard M; Le Feuvre C; Zaman AG
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
[TBL] [Abstract][Full Text] [Related]
36. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
37. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
Lefebvre CW; Hoekstra J
Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Performance of the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) bleeding score in a contemporary Spanish cohort of patients with non-ST-segment elevation acute myocardial infarction.
Abu-Assi E; Gracía-Acuña JM; Ferreira-González I; Peña-Gil C; Gayoso-Diz P; González-Juanatey JR
Circulation; 2010 Jun; 121(22):2419-26. PubMed ID: 20497978
[TBL] [Abstract][Full Text] [Related]
39. Short-term triple therapy with aspirin, warfarin, and a thienopyridine among patients undergoing percutaneous coronary intervention.
Porter A; Konstantino Y; Iakobishvili Z; Shachar L; Battler A; Hasdai D
Catheter Cardiovasc Interv; 2006 Jul; 68(1):56-61. PubMed ID: 16763985
[TBL] [Abstract][Full Text] [Related]
40. Optimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stenting.
Zinn A; Feit F
Am J Cardiol; 2009 Sep; 104(5 Suppl):49C-54C. PubMed ID: 19695362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
